Jimmy and Roya discuss the topic of cancer in honor of World Cancer Day.

SOURCES

Tepezza: https://www.healio.com/endocrinology/thyroid/news/online/%7Bba53d7c2-3140-4550-b027-63210804d2fb%7D/fda-approves-teprotumumab-for-thyroid-eye-disease

https://www.mayoclinic.org/diseases-conditions/cancer/symptoms-causes/syc-20370588

Teprotumumab for the Treatment of Active Thyroid Eye Disease: https://www.nejm.org/doi/full/10.1056/NEJMoa1910434

FDA Peanut Allergy: https://www.sciencealert.com/the-fda-just-approved-its-first-drug-to-treat-peanut-allergies-in-kids

Ocuphire researching DR Meds: https://www.businesswire.com/news/home/20200122005250/en/Ocuphire-Pharma-Announces-In-License-Phase-2-Oral

Breast cancer medications and vision: https://www.ncbi.nlm.nih.gov/pubmed/21819259

https://www.aao.org/eyenet/article/watch-ocular-effects-of-breast-cancer-drugs

Cancer Medications + Eye: https://www.uptodate.com/contents/ocular-side-effects-of-systemically-administered-chemotherapy#H27978392

http://www.hoajonline.com/jctr/2049-7962/1/5

https://moffitt.org/media/5066/150.pdf

https://www.lls.org/treatment/types-of-treatment/stem-cell-transplantation/graft-versus-host-disease

https://www.nature.com/articles/s41409-018-0090-z

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318713/

https://www.aao.org/eyenet/article/ocular-graftvshost-disease-downside-of-success-2